Dates of 2026 Scientific Advice Working Party (SAWP) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests

Timetable: Annual renewal application of conditional marketing authorisation

Timetable: Annual reassessment - ATMP

Timetable: Annual renewal application of conditional marketing authorisation - ATMP

Timetable: Annual renewal application of conditional marketing authorisation - ATMP

Timetable: Marketing authorisation renewal application - ATMP

PSUSA/00001804/202412

Human medicines European public assessment report (EPAR): Nimvastid, rivastigmine, Date of authorisation: 11/05/2009, Revision: 13, Status: Authorised

Orphan designation: Humanised IgG1 monoclonal antibody against human eotaxin-2,nebokitug Treatment of primary sclerosing cholangitis, 21/08/2020 Positive

Orphan designation: Felzartamab Treatment of primary IgA nephropathy, 11/11/2024 Positive